Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 — a pilot study

Key Points

• Sexual dysfunction is significantly associated with orexin-A and calpain-2 levels in individuals with multiple sclerosis.
• The measurement of orexin-A and calpain-2 provides potential biomarkers for assessing sexual dysfunction.
• Observational analysis involving patients with multiple sclerosis explores the roles of orexin-A and calpain-2 in sexual health.
• These findings highlight the need for further investigation into orexin-A and calpain-2 as treatment targets for sexual dysfunction.